HCA Healthcare 3Q 2026: Revenue $19.849B, Net income $1.579B, EPS $7.27— 10-Q Summary
HCA Healthcare reported 3Q 2026 revenue of $19.849B, up 3.6% YoY, with net income declining 3.9% to $1.579B. EPS rose 4.5% to $7.27. Admissions increased, but surgeries declined. Uninsured admissions surged 27.4%, pressuring managed-care revenue. Costs varied, with efficiency initiatives underway. Capital spending is projected at $5.0B-$5.5B, excluding acquisitions.
How this was made
The 30-second read
Why it matters
Traders can use the reported quarter metrics and operating drivers (admissions mix, surgery volumes, cost structure, uninsured admissions) to reassess near-term earnings power and margin risk.
Market read
A fresh quarterly disclosure with specific income statement figures and operating drivers that can shift expectations for margins and reimbursement dynamics.
What to watch
The summary flags inflation-driven expense pressure and managed-care revenue pressure, but does not quantify guidance or segment margins, which may be the key swing factor for traders.
Background
The piece is an AI summary of HCA’s 3Q 2026 10-Q filed Oct. 29, 2026, highlighting revenue, net income, EPS, and selected operating metrics.
Ticker impact
HCA reported 3Q 2026 revenue of $19.849B (+3.6% YoY) and diluted EPS of $7.27 (+4.5% YoY) in its 10-Q summary.
Likely mixed market reaction as EPS rises but net income falls, with investors focusing on managed-care pressure and cost inflation.
The article provides the quarter’s core income statement metrics and specific operating drivers (uninsured admissions up, inpatient/outpatient surgery declines, expense mix shift), which can offset each other for near-term sentiment.
Market effects
Hospital operators may face similar managed-care and cost inflation dynamics; admissions mix shifts (uninsured up) can pressure revenue quality.
No explicit regional breakdown provided; impact is primarily company-specific within US healthcare services.
Limited global relevance; US healthcare demand and reimbursement mix are the main themes.
Counterpoint
EPS growth could be driven by fewer diluted shares rather than underlying operating leverage, so the quality of earnings may be weaker than headline EPS suggests.
Key entities
- companyHCA Healthcare, Inc.
US hospital operator reporting 3Q 2026 revenue, net income, EPS, and operating highlights in a 10-Q summary.
